Patents by Inventor Sharad Magar

Sharad Magar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6288123
    Abstract: The present invention provides therapeutically useful substituted guanidines, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 11, 2001
    Assignee: Cambridge NeuroSciences, Inc.
    Inventors: Stanley M. Goldin, James B. Fischer, Andrew Gannett Knapp, N. Laxma Reddy, David Berlove, Graham J. Durant, Subbarao Katragadda, Lain-Yen Hu, Sharad Magar, Wenhong Fan, Elizabeth Yost, Jun Qing Guo
  • Patent number: 6235755
    Abstract: The present invention provides non-peptidic amino derivatives, their therapeutic use as well as pharmaceutical compositions that possess activity as Follicle Stimulating Hormone (FSH) agonists and are useful in the for treatment of infertility. In particular, the invention provides cyclic and acyclic alpha- and beta-aminocarboxamides, more particularly tetrahydroisoquinolinecarboxamides, piperidinecarboxamides, pyrrolidinecarboxamides, and 2-amino-3-carboxamidopyridine derivatives.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: May 22, 2001
    Assignee: Applied Research Systems ARS Holding N.A.
    Inventors: Nabil El Tayer, Adulla Reddy, David Buckler, Sharad Magar
  • Patent number: 6174924
    Abstract: The present invention provides therapeutically useful substituted guanidines, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 16, 2001
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Stanley M. Goldin, James B. Fischer, Andrew Gannett Knapp, N. Laxma Reddy, David Berlove, Graham J. Durant, Subbarao Katragadda, Lain-Yen Hu, Sharad Magar, Wenhong Fan, Elizabeth Yost, Jun Qing Guo
  • Patent number: 6156741
    Abstract: The present invention provides therapeutically useful substituted guanidines of the following Formula: ##STR1## and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 5, 2000
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Graham J. Durant, Sharad Magar, Lain-Yen Hu
  • Patent number: 6153604
    Abstract: The present invention provides therapeutically useful substituted guanidines of the following Formula: ##STR1## and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 28, 2000
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Graham J. Durant, Sharad Magar, Lain-Yen Hu
  • Patent number: 6147063
    Abstract: The present invention provides therapeutically useful substituted guanidines of the following Formula: ##STR1## and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 14, 2000
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Graham J. Durant, Sharad Magar, Lain-Yen Hu
  • Patent number: 6143791
    Abstract: The present invention provides therapeutically useful substituted guanidines, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 7, 2000
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Stanley M. Goldin, James B. Fischer, Andrew Gannett Knapp, N. Laxma Reddy, David Berlove, Graham J. Durant, Subbarao Katragadda, Lain-Hu Hu, Sharad Magar, Wenhong Fan, Elizabeth Yost, Jun Qing Guo
  • Patent number: 6025355
    Abstract: The present invention relates to pharmaceutically acceptable compounds, including certain substituted indolinyl and derivatives thereof, 1,2,3,4-tetrahydroquinolinyl and derivatives thereof, 1,2,3,4-tetrahydroisoquinolinyl, benz[cd]indolinyl and 5,6-dihydrophenanthridinyl compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for the treatment or prophylaxis of neurological injury and neurodegenerative disorders.
    Type: Grant
    Filed: May 19, 1997
    Date of Patent: February 15, 2000
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: N. Laxma Reddy, Michael Maillard, David Berlove, Sharad Magar, Graham J. Durant
  • Patent number: 6013675
    Abstract: The present invention provides therapeutically useful substituted guanidines and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 11, 2000
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Graham J. Durant, Lain-Yen Hu, Sharad Magar
  • Patent number: 5955507
    Abstract: The present invention provides therapeutically useful substituted guanidines and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: September 21, 1999
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Graham J. Durant, Lain-Yen Hu, Sharad Magar
  • Patent number: 5922772
    Abstract: The present invention provides therapeutically useful substituted guanidines and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: July 13, 1999
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Graham J. Durant, Lain-Yen Hu, Sharad Magar
  • Patent number: 5847006
    Abstract: The present invention provides N,N'-diaryl substituted guanidines having therapeutic utility. The compounds of the present invention are represented by the formula: ##STR1## wherein R and R.sup.1 represent hydrogen or other group and Ar and Ar.sup.1 represent selected aryl groups, and at least one being acenaphthyl.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: December 8, 1998
    Assignee: Cambridge NeuroScience, Inc.
    Inventors: Sharad Magar, Graham J. Durant, Lain-Yen Hu, Stanley M. Goldin, N. Laxma Reddy, James B. Fischer, Subbarao Katragadda, Andrew Gannett Knapp, Lee David Margolin